Data for: A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – MicroPET/CT imaging in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts

Name: Data for: A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – MicroPET/CT imaging in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts
Creator: Raymond Reilly
Published: 2020-01-12T13:43:49.644Z
Keywords: Radiopharmaceutical Agent

Reilly, Raymond; Winnik, Mitchell; Al-saden, Noor; Cho, Hyungjun; Lam, Heather; Möbus, Juri

doi:10.17632/5cbsywdybr.1

Data for: A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – MicroPET/CT imaging in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts

Published: 12 January 2020| Version 1 | DOI: 10.17632/5cbsywdybr.1

Contributors:

Raymond Reilly, Mitchell Winnik, Noor Al-saden, Hyungjun Cho, Heather Lam, Juri Möbus

Description

Supporting Information for: Cho H, Al-saden N, Lam H, Mobus J, Reilly RM, Winnik MA. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts. Nucl. Med. Biol. (submitted) September 18, 2019.

Data for: A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – MicroPET/CT imaging in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts

Description

Files

Categories

Licence